{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,24]],"date-time":"2025-12-24T03:07:40Z","timestamp":1766545660116},"reference-count":14,"publisher":"Editorial Committee of Annals of Thoracic and Cardiovascular Surgery","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["ATCS","Ann Thorac Cardiovasc Surg"],"published-print":{"date-parts":[[2022]]},"DOI":"10.5761\/atcs.cr.20-00257","type":"journal-article","created":{"date-parts":[[2021,1,19]],"date-time":"2021-01-19T22:06:09Z","timestamp":1611093969000},"page":"302-306","source":"Crossref","is-referenced-by-count":3,"title":["Perioperative Bypassing Agent Therapy for  Pulmonary Pleomorphic Carcinoma with  Acquired Hemophilia"],"prefix":"10.5761","volume":"28","author":[{"given":"Takashi","family":"Sakai","sequence":"first","affiliation":[{"name":"Division of Chest Surgery, Department of Surgery, Toho University School of Medicine, Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoko","family":"Azuma","sequence":"additional","affiliation":[{"name":"Division of Chest Surgery, Department of Surgery, Toho University School of Medicine, Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsushi","family":"Sano","sequence":"additional","affiliation":[{"name":"Division of Chest Surgery, Department of Surgery, Toho University School of Medicine, Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sota","family":"Sadamoto","sequence":"additional","affiliation":[{"name":"Department of Surgical Pathology, Toho University School of Medicine, Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naobumi","family":"Tochigi","sequence":"additional","affiliation":[{"name":"Department of Surgical Pathology, Toho University School of Medicine, Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daisuke","family":"Nagase","sequence":"additional","affiliation":[{"name":"Division of Hematology and Oncology, Department of Internal Medicine, Toho University School of Medicine, Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akira","family":"Iyoda","sequence":"additional","affiliation":[{"name":"Division of Chest Surgery, Department of Surgery, Toho University School of Medicine, Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"3757","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Hay CR, Brown S, Collins PW, et al. The diagnosis and management of factor VIII and IX inhibitors: a guideline from the United Kingdom Haemophilia Centre Doctors Organisation. Br J Haematol 2006; 133: 591\u2013605.","DOI":"10.1111\/j.1365-2141.2006.06087.x"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Franchini M, Vaglio S, Marano G, et al. Acquired hemophilia A: a review of recent data and new therapeutic options. Hematology 2017; 22: 514\u201320.","DOI":"10.1080\/10245332.2017.1319115"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Kruse-Jarres R, Kempton CL, Baudo F, et al. Acquired hemophilia A: updated review of evidence and treatment guidance. Am J Hematol 2017; 92: 695\u2013705.","DOI":"10.1002\/ajh.24777"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Takedani H, Shima M, Horikoshi Y, et al. Ten-year experience of recombinant activated factor VII use in surgical patients with congenital haemophilia with inhibitors or acquired haemophilia in Japan. Haemophilia 2015; 21: 374\u20139.","DOI":"10.1111\/hae.12611"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Ma AD, Kessler CM, HaB Al-Mondhiry, et al. US experience with recombinant factor VIIa for surgery and other invasive procedures in acquired haemophilia: analysis from the hemostasis and thrombosis research society registry. Haemophilia 2016; 22: e18\u201324.","DOI":"10.1111\/hae.12852"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Collins PW, Chalmers E, Hart DP, et al. Diagnosis and treatment of factor VIII and IX inhibitors in congenital haemophilia:(4th edition). UK Haemophilia Centre Doctors Organization. Br J Haematol 2013; 160: 153\u201370.","DOI":"10.1111\/bjh.12091"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Matsumoto T, Shima M, Fukuda K, et al. Immunological characterization of factor VIII autoantibodies in patients with acquired hemophilia A in the presence or absence of underlying disease. Thromb Res 2001; 104: 381\u20138.","DOI":"10.1016\/S0049-3848(01)00385-1"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Green D, Lechner K. A survey of 215 non-hemophilic patients with inhibitors to Factor VIII. Thromb Haemost 1981; 45: 200\u20133.","DOI":"10.1055\/s-0038-1650169"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Morrison AE, Ludlam CA, Kessler C. Use of porcine factor VIII in the treatment of patients with acquired hemophilia. Blood 1993; 81: 1513\u201320.","DOI":"10.1182\/blood.V81.6.1513.1513"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Bossi P, Cabane J, Ninet J, et al. Acquired hemophilia due to factor VIII inhibitors in 34 patients. Am J Med 1998; 105: 400\u20138.","DOI":"10.1016\/S0002-9343(98)00289-7"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Collins PW, Hirsch S, Baglin TP, et al. Acquired hemophilia A in the United Kingdom: a 2-year national surveillance study by the United Kingdom Haemophilia Centre Doctors&apos; Organisation. Blood 2007; 109: 1870\u20137.","DOI":"10.1182\/blood-2006-06-029850"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Sallah S, Wan JY. Inhibitors against factor VIII in patients with cancer. Analysis of 41 patients. Cancer 2001; 91: 1067\u201374.","DOI":"10.1002\/1097-0142(20010315)91:6<1067::AID-CNCR1101>3.0.CO;2-4"},{"key":"13","unstructured":"13) Ben Haim G, Manor U, Appel S, et al. Acquired hemophilia A in a patient with non-small cell lung carcinoma: a rare paraneoplastic phenomenon. Isr Med Assoc J 2017; 19: 128\u201330."},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Hauser I, Lechner K. Solid tumors and factor VIII antibodies. Thromb Haemost 1999; 82: 1005\u20137.","DOI":"10.1055\/s-0037-1614318"}],"container-title":["Annals of Thoracic and Cardiovascular Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/atcs\/28\/4\/28_cr.20-00257\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,20]],"date-time":"2022-08-20T04:57:05Z","timestamp":1660971425000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/atcs\/28\/4\/28_cr.20-00257\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022]]},"references-count":14,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.5761\/atcs.cr.20-00257","relation":{},"ISSN":["1341-1098","2186-1005"],"issn-type":[{"value":"1341-1098","type":"print"},{"value":"2186-1005","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022]]},"article-number":"cr.20-00257"}}